A sensitive determination of uric acid in serum using uricase/catalase/formaldehyde dehydrogenase coupled with formate dehydrogenase

Yuzo Kayamori, Yoshiaki Katayama

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

We developed and evaluated an assay for serum uric acid based on the uricase (EC 1.7.3.3)-catalase (EC 1.11.1.6)-formaldehyde dehydrogenase (FADH, EC 1.2.1.46) method coupled with formate dehydrogenase (formate: NAD oxidoreductase, FDH, EC 1.2.1.2). Formate dehydrogenase from Pseudomonas oxalaticus catalyzes the formation of NADH from formate produced by FADH. Owing to the NADH and formate oxidase activity of the FDH itself, the full reaction curve is not linear, but gradually decreases. The formation of NADH is not stoichiometric with formate removal, but is strictly proportional to it. To overcome this decrease of extinction, we added hydroxylamine hydrochloride to the FDH. The sensitivity of the full reaction in the presence of FDH was about 1.8 times that without FDH. Analysis with a Cobas Bio centrifugal analyzer revealed a linearity of up to 3.56 mmol/L. The uricase-catalase-alcohol dehydrogenase method correlated well with the uricase-peroxidase-chromagen method. Our method is more sensitive than other methods.

Original languageEnglish
Pages (from-to)93-97
Number of pages5
JournalClinical Biochemistry
Volume27
Issue number2
DOIs
Publication statusPublished - Jan 1 1994

Fingerprint

formic acid
glutathione-independent formaldehyde dehydrogenase
Formate Dehydrogenases
Urate Oxidase
Uric Acid
NAD
Catalase
Serum
Hydroxylamine
Alcohol Dehydrogenase
Peroxidase
Assays
Oxidoreductases
Pseudomonas

All Science Journal Classification (ASJC) codes

  • Clinical Biochemistry

Cite this

A sensitive determination of uric acid in serum using uricase/catalase/formaldehyde dehydrogenase coupled with formate dehydrogenase. / Kayamori, Yuzo; Katayama, Yoshiaki.

In: Clinical Biochemistry, Vol. 27, No. 2, 01.01.1994, p. 93-97.

Research output: Contribution to journalArticle

@article{d5488aa780ec47b29d89ccf88ec7feb7,
title = "A sensitive determination of uric acid in serum using uricase/catalase/formaldehyde dehydrogenase coupled with formate dehydrogenase",
abstract = "We developed and evaluated an assay for serum uric acid based on the uricase (EC 1.7.3.3)-catalase (EC 1.11.1.6)-formaldehyde dehydrogenase (FADH, EC 1.2.1.46) method coupled with formate dehydrogenase (formate: NAD oxidoreductase, FDH, EC 1.2.1.2). Formate dehydrogenase from Pseudomonas oxalaticus catalyzes the formation of NADH from formate produced by FADH. Owing to the NADH and formate oxidase activity of the FDH itself, the full reaction curve is not linear, but gradually decreases. The formation of NADH is not stoichiometric with formate removal, but is strictly proportional to it. To overcome this decrease of extinction, we added hydroxylamine hydrochloride to the FDH. The sensitivity of the full reaction in the presence of FDH was about 1.8 times that without FDH. Analysis with a Cobas Bio centrifugal analyzer revealed a linearity of up to 3.56 mmol/L. The uricase-catalase-alcohol dehydrogenase method correlated well with the uricase-peroxidase-chromagen method. Our method is more sensitive than other methods.",
author = "Yuzo Kayamori and Yoshiaki Katayama",
year = "1994",
month = "1",
day = "1",
doi = "10.1016/0009-9120(94)90018-3",
language = "English",
volume = "27",
pages = "93--97",
journal = "Clinical Biochemistry",
issn = "0009-9120",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - A sensitive determination of uric acid in serum using uricase/catalase/formaldehyde dehydrogenase coupled with formate dehydrogenase

AU - Kayamori, Yuzo

AU - Katayama, Yoshiaki

PY - 1994/1/1

Y1 - 1994/1/1

N2 - We developed and evaluated an assay for serum uric acid based on the uricase (EC 1.7.3.3)-catalase (EC 1.11.1.6)-formaldehyde dehydrogenase (FADH, EC 1.2.1.46) method coupled with formate dehydrogenase (formate: NAD oxidoreductase, FDH, EC 1.2.1.2). Formate dehydrogenase from Pseudomonas oxalaticus catalyzes the formation of NADH from formate produced by FADH. Owing to the NADH and formate oxidase activity of the FDH itself, the full reaction curve is not linear, but gradually decreases. The formation of NADH is not stoichiometric with formate removal, but is strictly proportional to it. To overcome this decrease of extinction, we added hydroxylamine hydrochloride to the FDH. The sensitivity of the full reaction in the presence of FDH was about 1.8 times that without FDH. Analysis with a Cobas Bio centrifugal analyzer revealed a linearity of up to 3.56 mmol/L. The uricase-catalase-alcohol dehydrogenase method correlated well with the uricase-peroxidase-chromagen method. Our method is more sensitive than other methods.

AB - We developed and evaluated an assay for serum uric acid based on the uricase (EC 1.7.3.3)-catalase (EC 1.11.1.6)-formaldehyde dehydrogenase (FADH, EC 1.2.1.46) method coupled with formate dehydrogenase (formate: NAD oxidoreductase, FDH, EC 1.2.1.2). Formate dehydrogenase from Pseudomonas oxalaticus catalyzes the formation of NADH from formate produced by FADH. Owing to the NADH and formate oxidase activity of the FDH itself, the full reaction curve is not linear, but gradually decreases. The formation of NADH is not stoichiometric with formate removal, but is strictly proportional to it. To overcome this decrease of extinction, we added hydroxylamine hydrochloride to the FDH. The sensitivity of the full reaction in the presence of FDH was about 1.8 times that without FDH. Analysis with a Cobas Bio centrifugal analyzer revealed a linearity of up to 3.56 mmol/L. The uricase-catalase-alcohol dehydrogenase method correlated well with the uricase-peroxidase-chromagen method. Our method is more sensitive than other methods.

UR - http://www.scopus.com/inward/record.url?scp=0028299557&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028299557&partnerID=8YFLogxK

U2 - 10.1016/0009-9120(94)90018-3

DO - 10.1016/0009-9120(94)90018-3

M3 - Article

C2 - 8070073

AN - SCOPUS:0028299557

VL - 27

SP - 93

EP - 97

JO - Clinical Biochemistry

JF - Clinical Biochemistry

SN - 0009-9120

IS - 2

ER -